Downing Street ‘desperate’ to prevent president’s intervention over NHS rebates row
Downing Street ‘desperate’ to prevent president’s intervention over NHS rebates row
Copy link
Government prepares to boost spending on medicines to avoid a tariff hit
The US president has told GSK and AstraZeneca to ‘negotiate harder with foreign freeloading nations’
Ministers called on to protect drug supplies and NHS costs from transatlantic trade shock
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.
Critics say government hiding true cost of deal ‘despite being forced to admit financial burden will grow year on year’
